Signal active
Investment Firm
Overview
Alcon is a medical device manufacturing company that develops and manufactures innovative medicines and devices to serve the full life cycle of eye care needs. It specializes in the fields of ophthalmology pharmaceuticals and medical devices, eye care, and eye health.
The company was founded in 1945 and headquartered in Geneva, Switzerland.
Highlights
1945
Health Care
10001+
2
2
1
N/A
N/A
Location
Vernier, Geneve, Switzerland, Europe
Contact Information
Social
Profile Resume
Alcon, established in 1945 and headquartered in Switzerland, Europe., specializes in investments across Biotechnology, Health Care, Medical, Biopharma, Financial Services, Venture Capital, Impact Investing, Hedge Funds, Software, Computer Vision. The organization boasts a portfolio of 2 investments, with an average round size of $120.0M and 1 successful exits. Their recent investments include Aurion Biotechnologies, Deerfield, Petrichor Healthcare Capital Management, SensoMotoric Instruments (SMI). The highest investment round they participated in was $6.2B. Among their most notable exits are Aurion Biotechnologies and Deerfield. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.
Investment portfolio
2
0
2
1
Investments
2
Annouced Date | Organization Name | Industry | Money Raised |
---|---|---|---|
Nov 20, 2012 | SensoMotoric Instruments (SMI) | Software | null |
Apr 12, 2022 | Aurion Biotechnologies | Biotechnology | 120.0M |
Exits
1
Funding Timeline
2
0
0
Funding Rounds
2
Alcon has raised 2 rounds. Their latest funding was raised on Apr 12, 2022 from a Venture Round - Aurion Biotechnologies round.
Annouced Date | Transaction Name | Number of Investors | Money Raised | Lead Investor |
---|---|---|---|---|
Nov 20, 2012 | Venture Round - SensoMotoric Instruments (SMI) | - | 0 | - |
Apr 12, 2022 | Venture Round - Aurion Biotechnologies | - | 120.0M | - |
Investors
0
There is no funding round available on this profile
Fund raised
2
Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.
Annouced Date | Fund Name | Money Raised |
---|---|---|
May 10, 2013 | OTPPLESS | 1.0M |
May 11, 2013 | OTPPLESS | 1.0M |
Invest in industries
Recent Activity
News
Sep 10, 2024
thefly.com - Alcon management to meet with BTIG
News
Sep 02, 2024
Global Legal Chronicle - Ocumension Therapeutics’ Acquisition of Alcon’s Rights
News
Aug 22, 2024
Benzinga - Needham Maintains Buy on Alcon, Raises Price ...
News
Aug 21, 2024
Investing.com - Alcon shares drop on earnings miss
News
Aug 21, 2024
MarketScreener - Alcon: targets confirmed, but 2nd quarter disappointing
News
Aug 21, 2024
TradingView - Eye care group Alcon's Q2 sales lag forecasts, shares fall